- Companies
- Swire Pacific
Swire Pacific Valuation Multiples
Swire Pacific is valued at $16B as of September 2026, a 2.6x revenue multiple. In the last 12 months, Swire Pacific revenue was $12B and Swire Pacific EBITDA was $2.1B.
Swire Pacific Overview
About Swire Pacific
Swire Pacific is a Hong Kong-based conglomerate with interests in property, aviation, beverage, trading, and industrials. The property division, an 82% stake in Swire Properties, contributes more than half of the group's operating profit. The beverage division is one of two Coca-Cola bottlers in mainland China and also a bottler in Hong Kong, Taiwan, Thailand, Laos, Vietnam, and Cambodia. The aviation division consists of Haeco, an aircraft engineering company, and a 45% stake in Cathay Pacific. As of end December 2024, John Swire & Sons, the parent company, holds a 60% stake in Swire Pacific but has 68% of the voting rights through a dual-class share structure.
Founded
1940
HQ
Employees
47.7K
Website
Financials (LTM)
EV
$32B
Valuation Multiples
Start free trialSwire Pacific Financials
Swire Pacific reported last 12-month revenue of $12B and EBITDA of $2.1B.
In the same LTM period, Swire Pacific generated $2.4B in gross profit, $2.1B in EBITDA, and $1.4B in net income.
Swire Pacific P&L
In the most recent fiscal year, Swire Pacific reported revenue of $12B and EBITDA of $1.6B.
Swire Pacific is profitable as of last fiscal year, with gross margin of 37%, EBITDA margin of 14%, and net margin of 3%.
Financial data powered by Morningstar, Inc.
Swire Pacific Stock Performance
Swire Pacific has current market cap of $16B, and enterprise value of $32B.
Market Cap Evolution
Swire Pacific's stock price is $13.14.
Swire Pacific has an EPS (earnings per share) of $0.31.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $32B | $16B | -0.3% | - | - | - | $0.31 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSwire Pacific Valuation Multiples
Swire Pacific trades at 2.6x EV/Revenue multiple, and 15.0x EV/EBITDA.
Swire Pacific Financial Valuation Multiples
As of September 30, 2026, Swire Pacific has market cap of $16B and EV of $32B.
Swire Pacific has a P/E ratio of 11.6x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Swire Pacific Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Swire Pacific Margins & Growth Rates
Swire Pacific grew revenue by 8% and EBITDA by 42% in the last fiscal year.
In the most recent fiscal year, Swire Pacific reported gross margin of 37%, EBITDA margin of 14%, and net margin of 3%.
Swire Pacific Margins
Swire Pacific Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Swire Pacific Operational KPIs
Swire Pacific's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Swire Pacific's Rule of 40 is 27% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Swire Pacific's Rule of X is 39% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Swire Pacific Competitors
Swire Pacific competitors include Air China, Keppel, JDE Peet's, Henderson Land, Kerry Group, Singapore Airlines, Varun Beverages, NVR, Unibail-Rodamco-Westfield and DLF.
Most Swire Pacific public comparables operate across Real Estate Development, Airlines and Food & Beverages.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $26B | $5.1B | 1.8x | 1.6x | 8.8x | 10.7x | |||
| $4.7B | $1.4B | 5.2x | 4.5x | 17.2x | 23.8x | |||
| $11B | $1.7B | 1.8x | 1.7x | 11.9x | 10.5x | |||
| $3.3B | $1.1B | 7.8x | 7.1x | 22.7x | 24.0x | |||
| $7.7B | $1.3B | 2.3x | 2.3x | 14.0x | 12.4x | |||
| $16B | $3.3B | 1.0x | 1.0x | 5.0x | 4.6x | |||
| $2.2B | $559M | 7.0x | 5.8x | 27.0x | 25.1x | |||
| $10B | $1.8B | 1.6x | 1.7x | 9.1x | 11.3x | |||
This data is available for Pro users. Sign up to see all Swire Pacific competitors and their valuation data. Start Free Trial | ||||||||
Acquisitions by Swire Pacific
Swire Pacific has acquired 1 company to date.
Last acquisition by Swire Pacific was on March 14th 2024. Swire Pacific acquired DeltaHealth for undisclosed valuation.
Latest Acquisitions by Swire Pacific
| Description | DeltaHealth is a Shanghai-based healthcare provider operating cardiology clinics and hospitals specializing in cardiovascular treatments including angioplasty and pacemaker implantation. It manages facilities in China with interventional cardiology suites and cardiac rehab programs, serving over 50,000 patients annually under JCI accreditation standards. |
| HQ Country | |
| HQ City | Shanghai |
| Deal Date | 14 Mar 2024 |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Swire Pacific acquisitions and their M&A valuation multiples. Start Free Trial | |
Investments by Swire Pacific
Swire Pacific has invested in 4 companies to date.
Latest investment by Swire Pacific was on August 14th 2024. Swire Pacific invested in Pertamina Bina Medika IHC in their Strategic investment round.
Latest Investments by Swire Pacific
| Description | Pertamina Bina Medika IHC is Indonesia's state-owned health-care holding company and the coordinating parent for a nationwide network of hospitals and clinics. Commonly branded Indonesia Healthcare Corporation, it consolidates facilities associated with state-owned enterprises and provides hospital, specialist, diagnostic, laboratory and related patient services. The group aims to raise clinical standards, improve procurement and operations and expand access across Indonesia's large archipelago. Pertamina initially developed the platform, and the Indonesian government designated it as the national state-owned hospital holding company. In 2024 Indonesia Investment Authority and Swire Pacific entered a strategic partnership with the business to finance capacity, service-quality and operational development. The company earns revenue from clinical care, diagnostics and other hospital services delivered to individuals, insurers and institutions. | Delicious AI is a New York-based retail analytics company using 3D computer vision to scan shelf displays in supermarkets across the US. The platform analyzes facings, stockouts, and sales velocity with point cloud data, powering recommendation engines that optimize product assortments for double-digit lift. | Green Monday Holdings is a Hong Kong-based producer of plant-based meat alternatives, including OmniPork branded pork substitutes and ready-to-eat frozen meals. The company operates Green Common retail stores and cafes focused on vegetarian and vegan products across Asia. Founded in 2012, it supplies products to supermarkets like ParknShop and AEON, while its subsidiary Beyond Meat Asia markets pea protein innovations. Green Monday Holdings went public on the Hong Kong Stock Exchange in 2022 under stock code 1919. | Green Biologics is an Oxfordshire-based industrial biotechnology company developing fermentation technologies for renewable chemicals and fuels from biomass. Its platform converts sugars into butanol, acetone, and other platform chemicals using engineered Clostridium microbes. The firm licenses its processes to global partners in the biofuels sector. |
| HQ Country | ||||
| HQ City | Jakarta | Salt Lake City, UT | Hong Kong | Aberdeen |
| Deal Date | 14 Aug 2024 | 4 Apr 2022 | 22 Sep 2020 | 21 Jan 2015 |
| Round | Strategic investment | Seed | Series A | Series C |
| Raised | undisclosed | $1M | $70M | $42M |
| Investors | Indonesia Investment authority; Swire Pacific | Cary Jenkins; Swire Pacific; Brad Hansen; Taylor Nadauld | John Wood; May McCarthy; CPT Capital; Wang Leehom; Sino Group; Swire Pacific; Susan Rockefeller; Jefferies; The Rise Fund; James Cameron | Oxford Capital; Capricorn Partners; Sofinnova Partners; ConvergInce Holdings; Swire Pacific; Morningside |
| Valuation | undisclosed | undisclosed | undisclosed | undisclosed |
| EV/Revenue | ||||
| EV/EBITDA | ||||
This data is available for Pro users. Sign up to see all Swire Pacific investments and their VC round multiples. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Swire Pacific
| When was Swire Pacific founded? | Swire Pacific was founded in 1940. |
| Where is Swire Pacific headquartered? | Swire Pacific is headquartered in Hong Kong. |
| How many employees does Swire Pacific have? | As of today, Swire Pacific has over 47K employees. |
| Is Swire Pacific publicly listed? | Yes, Swire Pacific is a public company listed on HKEX. |
| What is the stock symbol of Swire Pacific? | Swire Pacific trades under 00019 ticker. |
| When did Swire Pacific go public? | Swire Pacific went public in 1973. |
| Who are competitors of Swire Pacific? | Swire Pacific main competitors include Air China, Keppel, JDE Peet's, Henderson Land, Kerry Group, Singapore Airlines, Varun Beverages, NVR, Unibail-Rodamco-Westfield, DLF. |
| What is the current market cap of Swire Pacific? | Swire Pacific's current market cap is $16B. |
| What is the current revenue of Swire Pacific? | Swire Pacific's last 12 months revenue is $12B. |
| What is the current revenue growth of Swire Pacific? | Swire Pacific revenue growth (NTM/LTM) is 6%. |
| What is the current EV/Revenue multiple of Swire Pacific? | Current revenue multiple of Swire Pacific is 2.6x. |
| What is the current EBITDA of Swire Pacific? | Swire Pacific's last 12 months EBITDA is $2.1B. |
| What is Swire Pacific's EBITDA margin? | Swire Pacific's last 12 months EBITDA margin is 17%. |
| What is the current EV/EBITDA multiple of Swire Pacific? | Current EBITDA multiple of Swire Pacific is 15.0x. |
| What is the current FCF of Swire Pacific? | Swire Pacific's last 12 months FCF is $1.2B. |
| What is Swire Pacific's FCF margin? | Swire Pacific's last 12 months FCF margin is 10%. |
| What is the current EV/FCF multiple of Swire Pacific? | Current FCF multiple of Swire Pacific is 27.0x. |
| How many companies Swire Pacific has acquired to date? | As of September 2026, Swire Pacific has acquired 1 company. |
| What was the largest acquisition by Swire Pacific? | None of the M&A deals Swire Pacific has completed have disclosed valuations. |
| What companies Swire Pacific acquired? | Swire Pacific acquired DeltaHealth. |
| In how many companies Swire Pacific has invested to date? | As of September 2026, Swire Pacific has invested in 4 companies. |
| What was the last Swire Pacific investment? | On 14th August 2024 Swire Pacific invested in Pertamina Bina Medika IHC, participating in a Strategic investment round, alongside Indonesia Investment authority. |
| In what companies Swire Pacific invested in? | Swire Pacific invested in Green Monday Holdings, Green Biologics, Delicious AI, and Pertamina Bina Medika IHC. |
See public comps similar to Swire Pacific
Lists including Swire Pacific
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




